{"transactions":[{"id":3827034,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":163821,"kind":"person","name":"Thiel Carsten","position":1,"cik":"0001633582","reported_name":"Thiel Carsten","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory stock option (right to buy)","published_at":"2018-09-04T20:38:34.000Z","date":"2018-08-31","kind":"grant","acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 31, 2018.  The shares underlying this option vest as to one-third (1/3) of the shares on August 31, 2019 and as to the remaining two-thirds (2/3) of the shares in 24 equal monthly installments thereafter."}],"balance_after":34000,"derivative":{"exercise_price":21.05,"expiration_date":"2028-08-30","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001209191-18-049208","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919118049208/doc4.xml","form_type":"4"}},{"id":3977792,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":163821,"kind":"person","name":"Thiel Carsten","position":1,"cik":"0001633582","reported_name":"Thiel Carsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-04-03T00:35:14.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":262500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% accelerated vesting on change of control"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"After twelve months from the Grant Date options vest 2.0833% monthly. All options vested 48 months from Grant Date."}],"balance_after":262500,"derivative":{"exercise_price":13.65,"exercise_date":"2019-04-29","expiration_date":"2028-03-29","underlying":"Common stock","underlying_shares":262500},"source":{"system":"sec-edgar","filing":"0000318306-18-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000031830618000002/primary_doc.xml","form_type":"4"}},{"id":3977791,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":163821,"kind":"person","name":"Thiel Carsten","position":1,"cik":"0001633582","reported_name":"Thiel Carsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-04-03T00:35:14.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":87500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% accelerated vesting on change of control"}],"balance_after":87500,"derivative":{"exercise_price":13.65,"exercise_date":"2019-03-29","expiration_date":"2028-03-29","underlying":"Common stock","underlying_shares":87500},"source":{"system":"sec-edgar","filing":"0000318306-18-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000031830618000002/primary_doc.xml","form_type":"4"}},{"id":4401334,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":163821,"kind":"person","name":"Thiel Carsten","position":1,"cik":"0001633582","reported_name":"Thiel Carsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-03-06T18:03:48.000Z","date":"2017-02-28","kind":"sale","acquired":false,"shares":3783,"price":131.01,"value":495610.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $130.70 - $131.69.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":33860,"source":{"system":"sec-edgar","filing":"0000899866-17-000067","document":"wf-form4_148884141474383.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000067/wf-form4_148884141474383.xml","form_type":"4"}},{"id":4415427,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":163821,"kind":"person","name":"Thiel Carsten","position":1,"cik":"0001633582","reported_name":"Thiel Carsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2017-03-01T19:45:12.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":14800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Stock option award under 2004 Incentive Plan.  25% vest on the first anniversary of the grant date, 1/16 every three months thereafter until fully vested over 4 years."}],"balance_after":29600,"derivative":{"exercise_price":131.25,"exercise_date":"2018-02-28","expiration_date":"2027-02-28","underlying":"Common Stock, par value $.0001 per share","underlying_shares":14800},"source":{"system":"sec-edgar","filing":"0000899866-17-000056","document":"wf-form4_148841549780217.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000056/wf-form4_148841549780217.xml","form_type":"4"}},{"id":4415426,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":163821,"kind":"person","name":"Thiel Carsten","position":1,"cik":"0001633582","reported_name":"Thiel Carsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-03-01T19:45:12.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Award of Restricted Stock Units under the 2004 Incentive Plan.  25% vests on each anniversary of the grant date."}],"balance_after":37643,"source":{"system":"sec-edgar","filing":"0000899866-17-000056","document":"wf-form4_148841549780217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000056/wf-form4_148841549780217.xml","form_type":"4"}},{"id":4415425,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":163821,"kind":"person","name":"Thiel Carsten","position":1,"cik":"0001633582","reported_name":"Thiel Carsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-03-01T19:45:12.000Z","date":"2017-02-28","kind":"sale","acquired":false,"shares":54,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $131.00 - $131.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":30143,"source":{"system":"sec-edgar","filing":"0000899866-17-000056","document":"wf-form4_148841549780217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000056/wf-form4_148841549780217.xml","form_type":"4"}},{"id":4415424,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":163821,"kind":"person","name":"Thiel Carsten","position":1,"cik":"0001633582","reported_name":"Thiel Carsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-03-01T19:45:12.000Z","date":"2017-02-27","kind":"sale","acquired":false,"shares":71,"price":131.2,"value":9315.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $131.00 - $131.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":30197,"source":{"system":"sec-edgar","filing":"0000899866-17-000056","document":"wf-form4_148841549780217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000056/wf-form4_148841549780217.xml","form_type":"4"}},{"id":4462579,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":163821,"kind":"person","name":"Thiel Carsten","position":1,"cik":"0001633582","reported_name":"Thiel Carsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-02-08T16:39:25.000Z","date":"2017-02-06","kind":"sale","acquired":false,"shares":165,"price":125.69,"value":20738.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $125.00 - $125.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":30268,"source":{"system":"sec-edgar","filing":"0000899866-17-000026","document":"wf-form4_148658995271085.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000026/wf-form4_148658995271085.xml","form_type":"4"}},{"id":4524535,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":163821,"kind":"person","name":"Thiel Carsten","position":1,"cik":"0001633582","reported_name":"Thiel Carsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2016-12-13T18:24:48.000Z","date":"2016-12-09","kind":"sale","acquired":false,"shares":2308,"price":130,"value":300040.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act."}],"balance_after":30433,"source":{"system":"sec-edgar","filing":"0000899866-16-000393","document":"wf-form4_148167147614007.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986616000393/wf-form4_148167147614007.xml","form_type":"4"}},{"id":4578578,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":163821,"kind":"person","name":"Thiel Carsten","position":1,"cik":"0001633582","reported_name":"Thiel Carsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2016-10-18T18:29:57.000Z","date":"2016-10-14","kind":"sale","acquired":false,"shares":4584,"price":120.28,"value":551363.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act."}],"balance_after":32741,"source":{"system":"sec-edgar","filing":"0000899866-16-000367","document":"wf-form4_147682978520075.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986616000367/wf-form4_147682978520075.xml","form_type":"4"}},{"id":4585304,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":163821,"kind":"person","name":"Thiel Carsten","position":1,"cik":"0001633582","reported_name":"Thiel Carsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2016-10-05T17:25:56.000Z","date":"2016-10-03","kind":"sale","acquired":false,"shares":29,"price":122.41,"value":3549.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $122.00 - $122.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":37325,"source":{"system":"sec-edgar","filing":"0000899866-16-000365","document":"wf-form4_147570274345182.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986616000365/wf-form4_147570274345182.xml","form_type":"4"}},{"id":4603550,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":163821,"kind":"person","name":"Thiel Carsten","position":1,"cik":"0001633582","reported_name":"Thiel Carsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2016-09-14T16:34:08.000Z","date":"2016-09-13","kind":"sale","acquired":false,"shares":3000,"price":129,"value":387000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $129.00 - $129.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":37354,"source":{"system":"sec-edgar","filing":"0000899866-16-000355","document":"wf-form4_147388523627173.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986616000355/wf-form4_147388523627173.xml","form_type":"4"}},{"id":4603549,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":163821,"kind":"person","name":"Thiel Carsten","position":1,"cik":"0001633582","reported_name":"Thiel Carsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2016-09-14T16:34:08.000Z","date":"2016-09-12","kind":"sale","acquired":false,"shares":225,"price":124.2,"value":27945.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $124.00 - $124.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":40354,"source":{"system":"sec-edgar","filing":"0000899866-16-000355","document":"wf-form4_147388523627173.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986616000355/wf-form4_147388523627173.xml","form_type":"4"}},{"id":4608400,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":163821,"kind":"person","name":"Thiel Carsten","position":1,"cik":"0001633582","reported_name":"Thiel Carsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2016-09-08T16:33:17.000Z","date":"2016-09-06","kind":"sale","acquired":false,"shares":1000,"price":125.94,"value":125940.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $125.00 - $125.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":40579,"source":{"system":"sec-edgar","filing":"0000899866-16-000351","document":"wf-form4_147336677889789.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986616000351/wf-form4_147336677889789.xml","form_type":"4"}}]}